Ryu JH, Pellikka PA, Froehling DA, Peters SG, Aughenbaugh GL. Saddle pulmonary embolism diagnosed by CT angiography: frequency, clinical features and outcome. Respir Med. 2007;101(7):1537–42.
Sardi A, Gluskin J, Guttentag A, Kotler MN, Braitman LE, Lippmann M. Saddle pulmonary embolism: is it as bad as it looks? A community hospital experience. Crit Care Med. 2011;39(11):2413–8.
Prentice A, Ruiz I, Weeda ER. Saddle pulmonary embolism and in-hospital mortality in patients with cancer. Int J Clin Oncol. 2019;24(6):727–30.
Wong KJ, Kushnir M, Billett HH. Saddle pulmonary embolism: demographics, clinical presentation, and outcomes. Crit Care Explor. 2021;3(6): e0437.
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC), et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019;54(3):1901647.
Kochanek M, Kochanek J, Böll B, Eichenauer DA, Beutel G, Bracht H, et al. Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysis. Intensive Care Med. 2022;48(3):332–42.
Pineton de Chambrun M, Bréchot N, Combes A. Venoarterial extracorporeal membrane oxygenation in cardiogenic shock: indications, mode of operation, and current evidence. Curr Opin Crit Care. 2019;25(4):397–402.
Tonna JE, Abrams D, Brodie D, Greenwood JC, Rubio Mateo-Sidron JA, Usman A, et al. Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the Extracorporeal Life Support Organization (ELSO). ASAIO J. 2021;67(6):601–10.
Suzuki Y, Mobli K, Cass SH, Silva MM, DeAnda A, Tyler DS, et al. Extracorporeal membrane oxygenation for adult patients with neoplasms: outcomes and trend over the last 2 decades. ASAIO J. 2022. https://doi.org/10.1097/MAT.0000000000001740.
Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450–7.
Tsangaris A, Alexy T, Kalra R, Kosmopoulos M, Elliott A, Bartos JA, et al. Overview of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support for the management of cardiogenic shock. Front Cardiovasc Med. 2021;8: 686558.
Lüsebrink E, Zimmer S, Schrage B, Dabboura S, Majunke N, Scherer C, ICH-VA-ECMO Investigator Group. Intracranial haemorrhage in adult patients on venoarterial extracorporeal membrane oxygenation. Eur Heart J Acute Cardiovasc Care. 2022;11(4):303–11.
Jäämaa-Holmberg S, Salmela B, Suojaranta R, Lemström KB, Lommi J. Cost-utility of venoarterial extracorporeal membrane oxygenation in cardiogenic shock and cardiac arrest. Eur Heart J Acute Cardiovasc Care. 2020;9(4):333–41.
St-Onge M, Fan E, Mégarbane B, Hancock-Howard R, Coyte PC. Venoarterial extracorporeal membrane oxygenation for patients in shock or cardiac arrest secondary to cardiotoxicant poisoning: a cost-effectiveness analysis. J Crit Care. 2015;30(2):437.e7-14.
Dennis M, Zmudzki F, Burns B, Scott S, Gattas D, Reynolds C, ECMO Research Interest Group, et al. Cost effectiveness and quality of life analysis of extracorporeal cardiopulmonary resuscitation (ECPR) for refractory cardiac arrest. Resuscitation. 2019;139:49–56.
Gravesteijn BY, Schluep M, Voormolen DC, van der Burgh AC, Dos Reis MD, Hoeks SE, et al. Cost-effectiveness of extracorporeal cardiopulmonary resuscitation after in-hospital cardiac arrest: a Markov decision model. Resuscitation. 2019;143:150–7.
Hobohm L, Sagoschen I, Habertheuer A, Barco S, Valerio L, Wild J, et al. Clinical use and outcome of extracorporeal membrane oxygenation in patients with pulmonary embolism. Resuscitation. 2022;170:285–92.
Wang C, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, Thromboembolism (VTE) Study Group, et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest. 2010;137(2):254–62.
McMichael ABV, Ryerson LM, Ratano D, Fan E, Faraoni D, Annich GM. 2021 ELSO adult and pediatric anticoagulation guidelines. ASAIO J. 2022;68(3):303–10.
Karami M, Mandigers L, Miranda DDR, Rietdijk WJR, Binnekade JM, Knijn DCM, DUTCH ECLS Study Group. Survival of patients with acute pulmonary embolism treated with venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. J Crit Care. 2021;64:245–54.
Agerstrand CL, Burkart KM, Abrams DC, Bacchetta MD, Brodie D. Blood conservation in extracorporeal membrane oxygenation for acute respiratory distress syndrome. Ann Thorac Surg. 2015;99(2):590–5.
留言 (0)